Atossa Therapeutics, Inc.ATOSNASDAQ
Loading
Operating Income Growth AcceleratingAccelerating
Percentile Rank86
Studio
Year-over-Year Change

Year-over-year operating income growth rate

Latest
11.97%
↑ 191% vs avg
Percentile
P86
Within normal range
Streak
3 yr
Consecutive growthAccelerating
Average
-13.22%
Historical baseline
PeriodValue
202411.97%
2023-13.31%
2022-34.94%
2021-40.49%
202015.40%
2019-51.00%
2018-59.09%
20170.86%
201643.18%
2015-4.83%